Prevalence of Pulmonary Embolism Among Patients With COPD Hospitalized With Acutely Worsening Respiratory Symptoms:

Francis Couturaud, MD, PhD; Laurent Bertoletti, MD, PhD; Jean Pastre, MD; Pierre-Marie Roy, MD, PhD; Raphael Le Mao, MD; Frédéric Gagnadoux, MD, PhD; Nicolas Paleiron, MD, MS; Jeannot Schmidt, MD; Olivier Sanchez, MD, PhD; Elodie De Magalhaes, MD; Mariam Kamara, MD, MS1; Clément Hoffmann, MD; Luc Bressollette, MD, PhD; Michel Nonent, MD, PhD; Cécile Tromeur, MD, PhD; Pierre-Yves Salaun, MD, PhD; Sophie Barillot, MS; Florence Gatineau, MS; Patrick Mismetti, MD, PhD; Philippe Girard, MD; Karine Lacut, MD, PhD; Catherine A. Lemarié, PhD; Guy Meyer, MD; Christophe Leroyer, MD, PhD; for the PEP Investigators

5 January, 2021

NZ Respiratory Research Review Issue 190

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine:

Fernando P. Polack, M.D., Stephen J. Thomas, M.D., Nicholas Kitchin, M.D., Judith Absalon, M.D., Alejandra Gurtman, M.D., Stephen Lockhart, D.M., John L. Perez, M.D., Gonzalo Pérez Marc, M.D., Edson D. Moreira, M.D., Cristiano Zerbini, M.D., Ruth Bailey, B.Sc., Kena A. Swanson, Ph.D., Satrajit Roychoudhury, Ph.D., Kenneth Koury, Ph.D., Ping Li, Ph.D., Warren V. Kalina, Ph.D., David Cooper, Ph.D., Robert W. Frenck, Jr., M.D., Laura L. Hammitt, M.D., Özlem Türeci, M.D., Haylene Nell, M.D., Axel Schaefer, M.D., Serhat Ünal, M.D., Dina B. Tresnan, D.V.M., Ph.D., Susan Mather, M.D., Philip R. Dormitzer, M.D., Ph.D., Uğur Şahin, M.D., Kathrin U. Jansen, Ph.D., and William C. Gruber, M.D. for the C4591001 Clinical Trial Group

31 December, 2020

NZ Respiratory Research Review Issue 184

Risk Factors, Management, and Outcomes of Legionella Pneumonia in a Large, Nationally Representative Sample:

Joshua Allgaier, DO Tara Lagu, MD, MPH Sarah Haessler, MD Peter B. Imrey, PhD Abhishek Deshpande, MD, PhD Ning Guo, MS Michael B. Rothberg, MD, MPH

19 December, 2020

NZ Respiratory Research Review Issue 196

The Effect of Low Dose Corticosteroids and Theophylline on the Risk of Acute Exacerbations of COPD. The TASCS Randomised Controlled Trial:

Christine R. Jenkins, Fu-Qiang Wen, Allison Martin, Peter J. Barnes, Bartolome Celli, Nan-Shan Zhong, Jin-Ping Zheng, Anish Scaria, Gian-Luca Di Tanna, Thomas Bradbury, Norbert Berend on behalf of the TASCS study investigators

17 December, 2020

NZ Respiratory Research Review Issue 186

Fetal Origins of Asthma: A Longitudinal Study from Birth to Age 36 Years:

Stefano Guerra, Enrico Lombardi, Debra A. Stern, Duane L. Sherrill, Dorothy Gilbertson-Dahdal, Courtney M. Wheatley-Guy, Eric M. Snyder, Anne L. Wright, Fernando D. Martinez, and Wayne J. Morgan

15 December, 2020

NZ Respiratory Research Review Issue 182

The Relationship Between Asthma and Cardiovascular Disease:

Matias E. Pollevick, BS Kevin Y. Xu, MD, MPH Grace Mhango, MPH Emily G. Federmann, MS Rajesh Vedanthan, MD, MPH Paula Busse, MD Fernando Holguin, MD, MPH Alex D. Federman, MD, MPH Juan P. Wisnivesky, MD, DrPH

11 December, 2020

NZ Respiratory Research Review Issue 188

Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial:

Tracey A Day, PhD Adam Penn-Nicholson, PhD Angelique Kany Kany Luabeya, MBChB Andrew Fiore-Gartland, PhD Nelita Du Plessis, PhD Andre G Loxton, PhD Julie Vergara, BA Tom A Rolf, BS Tim D Reid, MSc Asma Toefy, BSc Justin Shenje, MBChB Hendrik Geldenhuys, MBChB Michele Tameris, MBChB Simbarashe Mabwe, MSc Nicole Bilek, PhD Prof Linda-Gail Bekker, MD Andreas Diacon, MD Prof Gerhard Walzl, MD Jill Ashman, MS Aude Frevol, RN Zachary K Sagawa, MS Cecilia Lindestam Arlehamn, PhD Alessandro Sette, PhD Steven G Reed, PhD Rhea N Coler, PhD Prof Thomas J Scriba, PhD Prof Mark Hatherill, MD the TBVPX-203 study team

8 December, 2020

NZ Respiratory Research Review Issue 187

Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial:

Tracey A Day, PhD Adam Penn-Nicholson, PhD Angelique Kany Kany Luabeya, MBChB Andrew Fiore-Gartland, PhD Nelita Du Plessis, PhD Andre G Loxton, PhD et al.

8 December, 2020

NZ Respiratory Research Review Issue 199

Adherence to disease-specific drug treatment among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension:

Barbro Kjellström, Anna Sandqvist, Clara Hjalmarsson, Magnus Nisell, Per Näsman, Bodil Ivarsson

7 December, 2020

NZ Respiratory Research Review Issue 183

A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial:

Raffael Nachbagauer, Jodi Feser, Abdollah Naficy, David I. Bernstein, Jeffrey Guptill, Emmanuel B. Walter, Franceso Berlanda-Scorza, Daniel Stadlbauer, Patrick C. Wilson, Teresa Aydillo, Mohammad Amin Behzadi, Disha Bhavsar, Carly Bliss, Christina Capuano, Juan Manuel Carreño, Veronika Chromikova, Carine Claeys, Lynda Coughlan, Alec W. Freyn, Christopher Gast, Andres Javier, Kaijun Jiang, Chiara Mariottini, Meagan McMahon, Monica McNeal, Alicia Solórzano, Shirin Strohmeier, Weina Sun, Marie Van der Wielen, Bruce L. Innis, Adolfo García-Sastre, Peter Palese & Florian Krammer

7 December, 2020

NZ Respiratory Research Review Issue 184